Janet Woodcock and Center for Drug Evaluation and Research

Selected healthcare news for the person - Janet Woodcock, and the healthcare topic - Center for Drug Evaluation and Research We have 206 shared news items for this connection to-date.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
1/19/2021 Janet Woodcock to Lead FDA on Interim Basis - WSJ The Wall Street Journal WASHINGTON‚AiJanet Woodcock, who has led the Food and Drug Administration‚Aos drug review efforts for years, is slated to oversee the agency on an interim basis after current Commissioner Stephen Hahn leaves Wednesday.President ... in 1986, and has most recently overseen the FDA‚Aos Center for Drug Evaluation and Research. During the past year, she has been on detail to the drug portion of Operation Warp Speed, the Trump ...
9/16/2020 Coronavirus antibody treatments: Eli Lilly, Regeneron, Vir, Amgen - Business Insider Business Insider ... Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research Reuters "These are very promising across the many stages of the disease, particularly the earlier stages," said Dr. Janet Woodcock, a longtime US Food and Drug Administration director now leading the US government's coronavirus drug research strategy. There are about 50 ongoing research programs to develop antibody drugs against COVID-19, Woodcock added on ...
7/29/2020 Operation Warp Speed: a timeline so far Becker's Hospital Review ... May 19: STAT obtained an email saying that two FDA officials who were named as overseers of Operation Warp Speed — Janet Woodcock, MD, and Peter Marks, MD, PhD — will recuse themselves from the agency's considerations ... step aside from her longtime role as director of the Center for Drug Evaluation and Research. On the same day, Dr. Hahn also released a series of tweets explaining that Dr. Marks was leaving Operation ...
6/21/2020 The FBI called a powerful opioid developed for the military a public threat. The company selling the drug says it'll save lives. Yahoo News ... Janet Woodcock, director of the Center for Drug Evaluation and Research at the FDA, called to tell him that Dsuvia had just been officially approved. “I told her that I thought that was a bad decision,” Brown, an anesthesiology professor and clinician at the University of Kentucky, said in a recent interview. “I told her exactly why.” Brown, who until recently headed the FDA’s advisory committee on analgesics and anesthetic ...
5/26/2020 FDA veteran reassigned to vaccine efforts + 4 more COVID-19 updates Becker's Hospital Review ... Janet Woodcock, MD, to focus on federal COVID-19 vaccine efforts , according to an internal email obtained by STAT . Dr. Woodcock will temporarily step aside from her longtime role as director of the Center for Drug Evaluation and Research to work on Operation Warp Speed, a federal initiative to accelerate the development of a COVID-19 vaccine. FDA Commissioner Stephen Hahn announced the change in an agencywide email May 22 ...
5/22/2020 FDA’s Woodcock to stop drug approval work to focus on Covid-19 vaccines STAT Politics FDA shuffles longtime division head, Janet Woodcock, to focus exclusively on Covid-19 vaccine project By Nicholas May 22, 2020 Reprints Janet Woodcock of the FDA. Tom Williams/CQ Roll Call/AP W ASHINGTON — Food and Drug Administration stalwart Janet Woodcock will temporarily step aside as the director of the agency’s Center for Drug Evaluation and Research to work solely on a White House initiative meant to accelerate Covid ...